BreezeBio Appoints Kevin Sin to Its Board of Directors SOUTH SAN FRANCISCO, Calif., September 15, 2026 — BreezeBio, Inc., formerly known as GenEdit, today announced the appointment of Kevin Sin to its Board of Directors as an independent director. Mr. Sin is a highly respected biopharmaceutical executive with more than 30 years of experience in […] The post BreezeBio Appoints Kevin Sin to Its Board of Directors first appeared on BreezeBio .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules